Table 5.
Preliminary Pharmacokinetic Screen of 2,6-Dimethyl-4-fluoro B-SERDs Compared to 2a
| plasma concentration (nM) |
brain concentration (nM) |
|||
|---|---|---|---|---|
| compound | 0.5 h | 2 h | 0.5 h | 2h |
| 2 | 31.2 ± 16.5 | 301 ± 268 | 0.7 ± 0.8b | 47.4 ± 61.1 |
| 30f | 786 ± 179 | 659 ± 329 | 750 ± 673 | 588 ± 274 |
| 30m | 211 ± 45 | 163 ± 141 | 121 ± 61 | 276 ± 93 |
| 37d | 2490 ± 797 | 2150 ± 201 | 1630 ± 1110 | 1250 ± 406 |
Plasma and brain concentration of 30f, 30m and 37d (100 mg/kg p.o.), and 2 (5 mg s.c.) showing mean and s.d. (N = 3).
Below LOQbrain = 5nM.